logo

For the Inventor, By the Inventor

Cold Spring Harbor, NY, United States of America

Grigori N Enikolopov

This inventor holds 5 USPTO granted patents. Top assignee: Cold Spring Harbor Laboratory. Active years: 1999-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Grigori N Enikolopov. Retrieved from https://idiyas.com/inventor/grigori-n-enikolopov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 40.0

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 111(Granted Patents)


Company Filing History:

goldMedal5 out of 197 
 
Cold Spring Harbor Laboratory
 patents

Years Active: 1999-2005

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6849662 - Therapeutic uses for nitric oxide inhibitors (2005-02-01),
2. 6809117 - Therapeutic uses of nitric oxide inhibitors (2004-10-26),
3. 6593372 - Therapeutic uses for nitric oxide inhibitors (2003-07-15),
4. 6372796 - Therapeutic uses for nitric oxide inhibitors (2002-04-16),
5. 5977181 - Therapeutic uses for nitric oxide inhibitors (1999-11-02),

Title: Grigori N Enikolopov: Innovator in Hematopoietic Stem Cell Research

Introduction

Grigori N Enikolopov is a prominent inventor based in Cold Spring Harbor, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of hematopoietic stem cells. With a total of 5 patents to his name, his work has the potential to impact therapeutic approaches in regenerative medicine.

Latest Patents

Enikolopov's latest patents focus on the therapeutic uses of nitric oxide inhibitors. One of his key inventions describes a method for increasing the population of hematopoietic stem cells in mammals. This method involves contacting hematopoietic tissue with inhibitors of nitric oxide synthase (NOS), which leads to an increased population of stem cells capable of normal hematopoiesis, differentiation, and maturation. Another patent outlines a method for regenerating tissue in adult mammals by using nitric oxide inhibitors to induce cell proliferation while inhibiting differentiation. These innovations highlight the importance of nitric oxide as a growth regulator in developing organisms.

Career Highlights

Grigori N Enikolopov is affiliated with Cold Spring Harbor Laboratory, where he conducts his research. His work has garnered attention for its potential applications in treating various medical conditions through the manipulation of stem cell populations. His innovative approaches have positioned him as a leading figure in his field.

Collaborations

Enikolopov has collaborated with notable colleagues, including Natalia I Peunova and Boris A Kuzin. These partnerships have contributed to the advancement of research in hematopoietic stem cell biology and therapeutic applications.

Conclusion

Grigori N Enikolopov's contributions to the field of stem cell research and his innovative patents on nitric oxide inhibitors underscore his role as a significant inventor in biomedical science. His work continues to pave the way for new therapeutic strategies in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…